Insider trading

Period: 120 months Stock: VIR + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

344 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

344 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

344 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

344 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
344 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
344 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

344 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
19 Aug 2021
SATO VICKI L Director
Sold, plan not stated 2×
$683.61K 15,174 at 45.05
0.9%
18 Aug 2021
Pang Phillip Chief Medical Officer
Sold, plan not stated
$211.16K 5,000 at 42.23
4.4%
10 Aug 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$56.38K 1,375 at 41.00
1.4%
4 Aug 2021
Pang Phillip Chief Medical Officer
Sold, plan not stated
$174.60K 5,000 at 34.92
4.4%
29 Jul 2021
MORE ROBERT J Director
Sold, plan not stated 2×
$429.72K 11,670 at 36.82
24.5%
27 Jul 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$50.49K 1,375 at 36.72
1.4%
21 Jul 2021
Pang Phillip Chief Medical Officer
Sold, plan not stated
$173.35K 4,630 at 37.44
4.1%
19 Jul 2021
SATO VICKI L Director
Sold, plan not stated 2×
$564.51K 15,174 at 37.20
0.9%
15 Jul 2021
MORE ROBERT J Director
Sold, plan not stated
$415.01K 11,670 at 35.56
20.2%
13 Jul 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$50.49K 1,375 at 36.72
1.4%
7 Jul 2021
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$201.93K 5,000 at 40.39
4.4%
1 Jul 2021
MORE ROBERT J Director
Sold, plan not stated 3×
$524.27K 11,670 at 44.92
16.8%
29 Jun 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$64.12K 1,375 at 46.63
1.4%
25 Jun 2021
Rice Steven J. Chief Administrative Officer
Sold, plan not stated
$150.00 3 at 50.00
0.0%
21 Jun 2021
SATO VICKI L Director
Sold, plan not stated 2×
$700.52K 15,174 at 46.17
0.9%
17 Jun 2021
MORE ROBERT J Director
Sold, plan not stated
$512.84K 11,670 at 43.95
14.4%
16 Jun 2021
Pang Phillip Chief Medical Officer
Sold, plan not stated
$218.35K 5,000 at 43.67
4.4%
15 Jun 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$62.27K 1,375 at 45.29
1.5%
3 Jun 2021
MORE ROBERT J Director
Sold, plan not stated
$520.03K 11,670 at 44.56
12.6%
2 Jun 2021
Pang Phillip Chief Medical Officer
Sold, plan not stated 2×
$414.87K 10,000 at 41.49
8.4%
1 Jun 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$58.45K 1,375 at 42.51
1.5%
20 May 2021
MORE ROBERT J Director
Sold, plan not stated 2×
$519.35K 11,670 at 44.50
11.6%
19 May 2021
SATO VICKI L Director
Sold, plan not stated 3×
$664.60K 15,174 at 43.80
0.9%
19 May 2021
Ramasastry Saira Director
Sold, plan not stated
$437.28K 10,000 at 43.73
100%
Sold half or more
18 May 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$61.92K 1,375 at 45.03
1.5%
4 May 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$63.29K 1,375 at 46.03
1.5%
27 Apr 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$391.08K 7,900 at 49.50
7.9%
19 Apr 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$112.32K 2,340 at 48.00
2.5%
13 Apr 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$242.24K 5,560 at 43.57
5.9%
1 Apr 2021
Parrish Jay Chief Business Officer
Sold, plan not stated
$356.96K 6,944 at 51.40
42.9%
23 Mar 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$423.41K 7,900 at 53.60
9.6%
10 Mar 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$112.32K 2,340 at 48.00
3.1%
9 Mar 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$249.09K 5,560 at 44.80
7.0%
1 Mar 2021
Parrish Jay Chief Business Officer
Sold, plan not stated
$440.53K 6,944 at 63.44
42.9%
23 Feb 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$503.58K 7,900 at 63.74
9.6%
9 Feb 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$562.16K 7,900 at 71.16
19.2%
1 Feb 2021
Parrish Jay Chief Business Officer
Sold, plan not stated
$485.42K 6,944 at 69.91
3.0%
26 Jan 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$1.51M 31,300 at 48.17
48.5%
15 Jan 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$400.14K 10,530 at 38.00
24.1%
12 Jan 2021
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$111.70K 3,805 at 29.36
10.3%
4 Jan 2021
Parrish Jay Chief Business Officer
Sold, plan not stated
$182.80K 6,945 at 26.32
3.0%
22 Dec 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$118.68K 3,805 at 31.19
13.8%
8 Dec 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$118.97K 3,805 at 31.27
13.8%
1 Dec 2020
Parrish Jay Chief Business Officer
Sold, plan not stated
$218.97K 6,945 at 31.53
3.0%
27 Nov 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$87.90K 2,930 at 30.00
11.0%
24 Nov 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$63.85K 2,340 at 27.29
9.0%
10 Nov 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$61.45K 2,340 at 26.26
9.0%
2 Nov 2020
Parrish Jay Chief Business Officer
Sold, plan not stated
$217.15K 6,944 at 31.27
3.0%
27 Oct 2020
Virgin Herbert EVP, Research & CSO
Sold, plan not stated
$133.33K 3,805 at 35.04
13.8%
21 Oct 2020
Pang Phillip Chief Medical Officer
Sold, plan not stated 3×
$600.82K 17,500 at 34.33
37.0%
Showing 251–300 of 344. ← Newer Page 6 of 7 Older →